NCT00681668View on ClinicalTrials.gov

Quetiapine in Postpartum Depression

PHASE2TerminatedINTERVENTIONAL

Enrollment

5

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions

Postpartum Depressive Disorder

Interventions

DRUG

Quetiapine

150-800 mg, oral, twice a day (bid)

Trial Locations (1)

Unknown

Research Site, Herten

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY